12:00 AM
 | 
Mar 11, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Vivus sales and marketing update

Vivus launched the Save Now! Program for obesity drug Qsymia phentermine/topiramate under which patients can receive a one-time, 30-day supply of the 7.5 mg/46 mg dose of Qsymia for no more than $75. According to Qsymia's label, patients should start at the lowest of the drug's four doses - 3.75 mg/23 mg - for 14 days and escalate to...

Read the full 284 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >